2024-10-10 2025-10-31 false Capium Accounts Production 1.1 16009870 2024-10-10 2025-10-31 16009870 bus:AbridgedAccounts 2024-10-10 2025-10-31 16009870 bus:FRS102 2024-10-10 2025-10-31 16009870 bus:AuditExemptWithAccountantsReport 2024-10-10 2025-10-31 16009870 bus:SmallCompaniesRegimeForAccounts 2024-10-10 2025-10-31 16009870 bus:PrivateLimitedCompanyLtd 2024-10-10 2025-10-31 16009870 2024-10-10 2025-10-31 16009870 2025-10-31 16009870 bus:RegisteredOffice 2024-10-10 2025-10-31 16009870 core:WithinOneYear 2025-10-31 16009870 core:AfterOneYear 2025-10-31 16009870 1 2024-10-10 2025-10-31 16009870 bus:Director1 2024-10-10 2025-10-31 16009870 bus:Director1 2025-10-31 16009870 2023-10-10 16009870 bus:LeadAgentIfApplicable 2024-10-10 2025-10-31 16009870 2024-10-09 16009870 bus:OrdinaryShareClass1 2024-10-10 2025-10-31 16009870 bus:OrdinaryShareClass1 2025-10-31 16009870 core:LandBuildings 2024-10-10 2025-10-31 16009870 core:LandBuildings 2025-10-31 16009870 core:LandBuildings 2024-10-09 16009870 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-10-31 16009870 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-10-09 16009870 core:CostValuation core:Non-currentFinancialInstruments 2025-10-31 16009870 core:CostValuation core:Non-currentFinancialInstruments 2024-10-09 16009870 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-10-31 16009870 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-10-31 16009870 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-10-31 16009870 core:Non-currentFinancialInstruments 2025-10-31 16009870 core:Non-currentFinancialInstruments 2024-10-09 16009870 core:ShareCapital 2025-10-31 16009870 core:RetainedEarningsAccumulatedLosses 2025-10-31 16009870 dpl:Item1 2024-10-10 16009870 dpl:Item1 2025-10-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 16009870
England and Wales

 

 

 


Abridged Accounts


for the period ended 31 October 2025

for

HEALTH CARE REVIVAL SOLUTIONS LIMITED

Health Care Revival Solutions Limited
Contents Page
For the Period 10 October 2024 to 31 October 2025
These financial statements have been prepared in accordance with our terms of engagement and in order to assist you to fulfil your duties under the Companies Acts that relate to preparing the financial statements of the company for the period ended 31 October 2025.

We have prepared these finance statements based on the accounting records, information and explanations provided by you. We do not express any opinion on the financial statements.

On the Balance Sheet you have acknowledged your duties under the prevailing Companies Acts to ensure that the company keeps adequate accounting records and prepares financial statements that give a true and fair view.

You have determined that the company is exempt from the statutory requirement for an audit for this accounting period. Therefore, the financial statements are unaudited.

The financial statements are provided exclusively to the director for the limited purpose mentioned above, and may not be used or relied upon for any other purpose or by any other person, and we shall not be liable for any other usage or reliance.



....................................................
MBS Accountants
Conway House
Worcester Street
Gloucester
GL1 3AJ
04 December 2025
1
 
 		 Notes
 		 2025
£
Fixed assets    
Tangible fixed assets 3 3,678 
3,678 
Current assets    
Debtors 8,287 
Cash at bank and in hand 462 
8,749 
Creditors: amount falling due within one year (3,266)
Net current assets 5,483 
 
Total assets less current liabilities 9,161 
Creditors: amount falling due after more than one year (2,196)
Net assets 6,965 
 

Capital and reserves 		   
Called up share capital 4 1 
Profit and loss account 6,964 
Shareholders' funds 6,965 
 


For the period ended 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006 the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 02 December 2025 and were signed by:


-------------------------------
Thomas McCullough
Director
2
General Information
Health Care Revival Solutions Limited is a private company, limited by shares, registered in England and Wales, registration number 16009870, registration address 53 Kenton Avenue Gosforth, Newcastle Upon Tyne, Tyne And Wear, NE3 4SE.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Going concern basis
The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current and deferred tax assets and liabilities are not discounted.
Dividends
Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Land and Buildings 20% Reducing Balance
2.

Average number of employees

Average number of employees during the period was 0.
3.

Tangible fixed assets

Cost or valuation Land and Buildings   Total
  £   £
At 10 October 2024 -    - 
Additions 4,598    4,598 
Disposals -    - 
At 31 October 2025 4,598    4,598 
Depreciation
At 10 October 2024 -    - 
Charge for period 920    920 
On disposals -    - 
At 31 October 2025 920    920 
Net book values
Closing balance as at 31 October 2025 3,678    3,678 
Opening balance as at 10 October 2024 -    - 


4.

Share Capital

Allotted, called up and fully paid
2025
£
1 Class A share of £1.00 each 1 
1 

3